FdaApplication
BLA 125788
Identifiers
- fda_app_no: BLA125788
Properties
| Property | Value |
|---|---|
| applicant_name | Genetix Biotherapeutics Inc. |
| application_type | BLA |
| approval_date | 2023-12-08 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LYFGENIA | — | 1.7-20x10^6CELL/ML | Suspension |
1 product